Imagine a world where living to 150 isn't just science fiction but a tangible goal. That's exactly what China is racing towards with a billion-dollar drive to unlock the secrets of longevity. This ambitious pursuit, fueled by both state and private investment, has transformed what was once considered quackery into a legitimate and rapidly advancing field of medicine. But here's where it gets controversial: while some see this as a groundbreaking leap for humanity, others question the ethics and feasibility of such a quest. Could we really live forever, and at what cost?
When Chinese leader Xi Jinping and Russian President Vladimir Putin were recently overheard discussing the possibility of living to 150 or even achieving immortality, the world took notice. While some dismissed it as casual chatter, others saw it as a glimpse into China's bold vision for the future. In the bustling city of Shenzhen, Lonvi Biosciences, a longevity medicine start-up, is at the forefront of this revolution. Lyu Qinghua, the company's chief technology officer, confidently declares, 'Living to 150 is definitely realistic. In a few years, this will be the reality.'
But Lonvi isn't alone in this pursuit. China's longevity industry has become a national priority, with billions poured into research and commercial ventures. This isn't a new obsession; the quest for eternal life dates back over two millennia to China's first emperor, Qin Shi Huang, who sought death-defying potions and even commissioned terra-cotta warriors to protect him in the afterlife. Ironically, he died at 49, possibly from mercury poisoning caused by an anti-aging treatment. And this is the part most people miss: despite its historical roots, the longevity industry has long been tainted by skepticism and pseudoscience. Yet, China's rapid advancements are changing the narrative.
China's average life expectancy now stands at 79 years, surpassing the global average but still trailing Japan's 85 years. However, the country's enthusiasm for extending lifespan has grown alongside its economic boom, giving millions the means to focus on more than just survival. Companies like Time Pie, a Shanghai-based group that started with dietary supplements and now organizes scientific conferences, are capitalizing on this trend. 'Nobody in China was talking about longevity before, only rich Americans,' says co-founder Gan Yu. 'Now many Chinese are interested and have the money to extend their lives.'
The surge in interest was evident at a recent international gathering in Shanghai, where scientists and businesses showcased everything from anti-aging creams to cryogenic chambers. While some offerings, like 'immortality islands' promoted by SuperiorMed, seem more like luxury fantasies, serious researchers like Harvard's Vadim Gladyshev and aging expert Steve Horvath are contributing to the field's credibility. Horvath notes that longevity science has moved beyond 'wild claims' and is now marked by 'vast improvement,' though the idea of immortality remains a tantalizing marketing tool.
Lonvi's approach is more grounded. Inspired by a 2021 study in Nature Metabolism that found a grapeseed extract compound extended the lifespan of mice, the company has developed anti-aging pills targeting 'zombie cells'—aging cells that harm healthy ones. While the study faced scrutiny over data errors, subsequent research has supported its findings. However, translating these results to humans requires rigorous testing, as David Barzilai, a medical doctor, cautions. 'China is increasingly taking longevity seriously, but strong scientific intent doesn't guarantee success,' he says. 'The challenge is doing better, not just more.'
Lonvi's CEO, Yip Tszho (Zico), believes their pills, combined with a healthy lifestyle, could help people live past 100. The Buck Institute at Stanford University plans to test these claims in clinical trials, adding a layer of scientific validation. Meanwhile, Zico sees a vast market, not just for humans but also for pets, drawing parallels to Qin Shi Huang's quest for immortality. 'Rich people are like Qin Shi Huang,' he says, 'looking for longer lives, if not immortality.'
But here’s the question that lingers: As China pushes the boundaries of longevity, are we prepared for the societal, ethical, and economic implications of a world where living to 150 becomes the norm? And if immortality remains out of reach, how far are we willing to go in pursuit of a longer life? Let’s discuss—what’s your take on this bold vision for the future?
